<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhao Z</submitter><funding>National Key Research and Development Program of China Stem Cell and Translational Research</funding><funding>Guangdong Provincial Natural Science Foundation</funding><funding>National Natural Science Foundation of China</funding><funding>Qingdao Municipal Science and Technology Bureau</funding><funding>National Key Research and Development Program of China</funding><funding>Taishan Scholar Foundation of Shandong Province</funding><pagination>102382</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11784501</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(1)</volume><pubmed_abstract>Definitive endoderm (DE) derived from human pluripotent stem cells (hPSCs) holds great promise for cell-based therapies and drug discovery. However, current DE differentiation methods required undefined components and/or expensive recombinant proteins, limiting their scalable manufacture and clinical use. Homogeneous DE differentiation in defined and recombinant protein-free conditions remains a major challenge. Here, by systematic optimization and high-throughput screening, we report a chemically defined, small-molecule-based defined system that contains only four components (4C), enabling highly efficient and cost-effective DE specification of hPSCs in the absence of recombinant proteins. 4C-induced DE can differentiate into functional hepatocytes, lung epithelium, and pancreatic β cells</pubmed_abstract><journal>Stem cell reports</journal><pubmed_title>Chemically defined and growth factor-free system for highly efficient endoderm induction of human pluripotent stem cells.</pubmed_title><pmcid>PMC11784501</pmcid><funding_grant_id>2022A1515011819</funding_grant_id><funding_grant_id>32200685</funding_grant_id><funding_grant_id>32471160</funding_grant_id><funding_grant_id>32430031</funding_grant_id><funding_grant_id>tsqn202306271</funding_grant_id><funding_grant_id>92268105</funding_grant_id><funding_grant_id>23-2-8-smjk-11-nsh</funding_grant_id><funding_grant_id>2023YFA1801200</funding_grant_id><pubmed_authors>En H</pubmed_authors><pubmed_authors>Chan WY</pubmed_authors><pubmed_authors>Cao N</pubmed_authors><pubmed_authors>Gu S</pubmed_authors><pubmed_authors>Lu G</pubmed_authors><pubmed_authors>Zeng F</pubmed_authors><pubmed_authors>Xu H</pubmed_authors><pubmed_authors>Zhao Z</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Nie Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Chemically defined and growth factor-free system for highly efficient endoderm induction of human pluripotent stem cells.</name><description>Definitive endoderm (DE) derived from human pluripotent stem cells (hPSCs) holds great promise for cell-based therapies and drug discovery. However, current DE differentiation methods required undefined components and/or expensive recombinant proteins, limiting their scalable manufacture and clinical use. Homogeneous DE differentiation in defined and recombinant protein-free conditions remains a major challenge. Here, by systematic optimization and high-throughput screening, we report a chemically defined, small-molecule-based defined system that contains only four components (4C), enabling highly efficient and cost-effective DE specification of hPSCs in the absence of recombinant proteins. 4C-induced DE can differentiate into functional hepatocytes, lung epithelium, and pancreatic β cells</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-06-01T08:59:30.98Z</modification><creation>2025-04-03T23:26:45.653Z</creation></dates><accession>S-EPMC11784501</accession><cross_references><pubmed>39729989</pubmed><doi>10.1016/j.stemcr.2024.11.012</doi></cross_references></HashMap>